| [1] | Portilla MI, Mafla AC, Arteaga JJ. Periodontal status in female psychiatric patients. Colombia Med. 2009; 40(2): 167-176 4. |
| [2] | Rindal D, Rush W, Peters D, Maupomé G. Antidepressant xerogenic medications and restoration rates. Community dentistry and oral epidemiology, (2005). 33(1): 74-80. |
| [3] | National Institute of Mental Health (NIMH).Depression. National Institutes of Health Publication No. 08 3561. Bethesda, MD: NIMH; 2008. |
| [4] | Deepak D and Gopakumar R. Xerostomia, its association with oral manifestation and ocular involvement: A clinical and Biochemical study. Journal of Indian Academy of Oral Medicine and Radiology, 2011; 23 (4):513-517. |
| [5] | Friedlander, A.H., Mahler, M.E. (2001). Major depressive disorder: Psychopathology, medical management and dental implications Am Dent Assoc, 132(5): 629–638. |
| [6] | McCreadie RG, Stevens H, Henderson J, et al. The dental health of people with schizophrenia. Acta Psychiatry Scand. 2004; 110(4):306-310. |
| [7] | Anttila S, Knuuttila M, Sakki T. Relationship of depressive symptoms to edentulousness, dental health, and dental health behavior. Acta Odontologica Scandinavia 2001; 59: 406-412. |
| [8] | Anttila, S., Knuuttila, M., Yiost alo, P., Joukamaa, M.(2006) Symptoms of depression and anxiety in relation to dental health behavior and self-perceived dental treatment need. Eur. J Oral Sci., 114(2):109–114. |
| [9] | Bardow A, Lagerlof F, Nauntofte B, et al. The role of saliva. In: Fejerskov O, Kidd E, eds. Dental caries: the disease and its clinical management. Oxford, United Kingdom: Blackwell Munksgaard; 2008:195. |
| [10] | Rettenbacher MA, Hofer A, Eder U, et al. Compliance in schizophrenia: psychopathology, side effects, and patients’ attitudes toward the illness and medication. J Clinical Psychiatry. 2004; 65(9):1211-1218. |
| [11] | Bulkacz J, Carranza FA. Defense mechanisms of the gingival In: Newman MG, Takei HH, Klokkevold PR, et al, eds. Carranza’s clinical periodontology. St. Louis, MO: Elsevier Saunders; 2011:69-70. |
| [12] | Sciubba JJ, Goldenberg D. Oral complications of radiotherapy. Lancet Oncology. 2006 Feb; 7(2):175-83. |
| [13] | National Institute of Dental and Craniofacial Research. Dry mouth. http://www.nidcr.nih.gov/oralhealth/topics/drymouth/drymouth.htm. Accessed Feb. 3, 2014. |
| [14] | Swager l and Morgan S. Psychotropic-induced dry mouth: Don’t overlook this potentially serious side effect. Current Psychiatry, 2011; 10(12): 54-58. |
| [15] | Hopcraft MS, Tan C. Xerostomia: an update for clinicians. Australian Dental Journal 2010; 55(3):238–44. |
| [16] | Orellana MF, Lagravere MO, Boychuk DG, Major PW, Flores-Mir C. Prevalence of xerostomia in population- based samples: a systematic review. Journal of Public Health Dentistry 2006; Vol. 66, issue 2:152–8. |
| [17] | Villa A, Abati S. Risk factors and symptoms associated with xerostomia: a cross-sectional study. Australian Dental Journal 2011; 56(3):290–5. |
| [18] | Mouly S J. Efficacy of a New Oral Lubricant Solution in the Management of Psychotropic Drug-Induced Xerostomia A Randomized Controlled Trial. Journal of Clinical Psychopharmacology 2007; 27:437–443. |
| [19] | Pai S1, Ghezzi EM, Ship JA. Development of a Visual Analogue Scale questionnaire for subjective assessment of salivary dysfunction. Oral Surg. Oral Med Oral Pathol Oral Radiol Endod. 2001 Mar; 91(3): 311-6. |
| [20] | Guggenheimer J, Moore PA. Xerostomia: etiology, recognition and treatment. J Am Dent Assoc. 2003; 134: 61–69. |
| [21] | Gotrick B, Akerman S, Ericson D, et al. Oral Pilocarpine for the treatment of opioid-induced oral dryness in healthy adults. J Dent Res.2004; 83: 393–397. |
| [22] | Keene JJ Jr1, Galasko GT, Land MF. (2003). Antidepressant use in psychiatry and medicine: importance for dental practice. J Am Dent Assoc. Jan; 134(1):71-9. |
| [23] | Clark, D, B. (1992). Dental care for psychiatrist patients: Chronic schizophrenia. Canadian Dental Association, 58(1), 912-916, 919-920. |
| [24] | Barnes, G.B., Allen, E.H., Parker, W.A., Lyon, T.C, Armentrout, W., & Cole, JS. Dental treatment needs among hospitalized adult mental patients. Special Care Dentistry. (1988). 8(4), 173-177. |
| [25] | Hede, B. Dental health behavior and Self reported dental health problems among hospitalized psychiatric patients in Denmark. Acta Odontol Scand, (1995)53(1), 35-40. |
| [26] | Heinssen, R .K., Liberman, R. P., & Kopelowicz, A. (2000). Psychosocial skills training for schizophrenia: Lessons from the laboratory. Schizophrenia Bulletin, 26(1), 21-46. |
| [27] | Furness S, Worthington HV, Bryan G, Birchenough S, McMillan R Interventions for the management of dry mouth: topical therapies (Review) 2011, Issue 12 http://www.thecochranelibrary.com. |
| [28] | Lauren W. M. Swager, MD& Susan K. Morgan, D. Psychotropic-induced dry mouth: Don’t overlook this potentially serious side effect. Med/Psych Update. Current Psychiatry 2011, 54. |
| [29] | Visvanathan V, Nix P. Managing the patient presenting with xerostomia: a review. International Journal of Clinical Practice 2010; 64(3):404–7. |
| [30] | Stetson B. A. (2000). Influence of behavioral science research on oral health promotion. Compend. Continue. Educ. DentSuppI, 30, 24-30. |
| [31] | Weeks JC, Fiske J. (1994). Oral care of people with disability: a qualitative exploration of the views of nursing staff. Jul; 11(1): 13-7 http://www.ncbi.nlm.nih.gov/Pub med/7713537 |
| [32] | Kisely S, Quek LH, Pais J, Lalloo R, Johnson NW, Lawrence D:Advanced dental disease in people with severe mental illness: systematic review and meta-analysis.Br J Psychiatry 2011, 199(3):187–93. |
| [33] | The Merck Manuals: The Merck Manual for Health Care Professionals. Xerostomia. At professional /dental_disorders/ symptoms_of_dental_and_oral_disorders/xerostomia.html. Accessed Feb. 3, 2014. http://www.merckmanuals.com/. |